Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Mankind Pharma Ltd

NSE: MANKIND · BSE: 543904 · Pharmaceuticals & Biotechnology · 50 announcements

Share price
₹2,500.00
Market cap
₹1,03,261 Cr
Revenue (annual)
₹14,278 Cr
Net profit (annual)
₹1,913 Cr
P/E (TTM)
50.5×Sector 47.4×
Promoter holding
72.63%-0.03% QoQ
FII holding
9.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:10 IST NSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring

Mankind Pharma announced that members of its wholly-owned subsidiary, Bharat Serums and Vaccines Limited (BSVL), approved its voluntary liquidation in an EGM.

16:38 IST BSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring

Mankind Pharma's board approved the voluntary liquidation of its subsidiary, Bharat Serums and Vaccines Limited, to integrate its business into the parent company.

21:37 IST NSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring Worth ₹55.06 Cr

Mankind Pharma has incorporated a wholly-owned subsidiary in the Netherlands, "Mankind Pharma (Netherlands) B.V.", with an issued capital of ₹55.06 Crore.

Value
₹55.06 Cr
21:28 IST BSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring

Mankind Pharma has incorporated a wholly-owned subsidiary, 'Mankind Pharma (Netherlands) B.V.', in the Netherlands as previously disclosed.